特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
599692

免疫学の世界市場:2018年~2022年

Global Immunology Market 2018-2022

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 117 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
免疫学の世界市場:2018年~2022年
出版日: 2018年01月08日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

免疫学について

免疫系は、ウイルス、細菌、癌などの有害なものから身体を保護します。それは細胞、分子のネットワークであり、身体全体に存在する器官です。免疫系は、体内に存在する異物を攻撃します。体は癌性細胞を含む異常細胞を同定し、破壊します。固有の自己防衛システムは、外来分子の同定において身体を助ける細胞を含みます。異なる経路は、身体の健康な細胞とウイルス(寄生虫、細菌、真菌、および癌細胞)のような病原性外来物質を区別するために、様々な免疫細胞を調節します。身体をさまざまな方法で攻撃しようとする継続的に進化する生物に対する身体の防御を維持するためには、免疫システムのすべての構成要素の継続的な改変が不可欠です。時には、連続的に改変する免疫系は、それらを外敵とみなして体細胞に対して反応し、健康な組織の破壊をもたらし、自己免疫疾患および癌の原因となります。免疫不全疾患を引き起こす遺伝的理由で体の防衛が弱まっているために、反応しない固有の状態が観察されることもあります。

Technavioのアナリストは、2018年から2222年の間に、世界の免疫学市場が4.57%のCAGRで成長すると予測しています。

当レポートでは、世界の市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 イントロダクション

  • 市場概要

第5章 市場状況

  • 市場の生態系
  • 市場特性
  • 市場セグメンテーション分析

第6章 市場規模

  • 市場の定義 
  • 市場規模:2017年
  • 市場規模と予測

第7章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市場状況

第8章 パイプラインの風景

第9章 市場セグメンテーション:カテゴリー別

  • セグメンテーション:カテゴリー別
  • 比較:カテゴリー別
  • 免疫抑制剤市場
  • 抗原抗体反応促進剤(Immuno Booster)市場
  • 市場機会:カテゴリ別

第10章 市場セグメンテーション:表示別

  • 自己免疫疾患
  • 腫瘍学
  • 臓器移植
  • その他

第11章 顧客情勢

第12章 地域情勢

  • 地理的セグメンテーション
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 市場機会

第13章 意思決定の枠組み

第14章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第15章 市場動向

  • 重要なパイプライン
  • R&Dのための共同研究とパートナーシップ
  • 先進診断技術

第16章 ベンダー情勢

  • 概要
  • 創造的破壊

第17章 ベンダー分析

  • 対象ベンダー
  • ベンダーの分類
  • ベンダーの市場ポジショニング
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

第18章 付録

  • 略語リスト
図表
  • Exhibit 01: Parent market
  • Exhibit 02: Global immunology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global immunology market 2017-2022 ($ billions)
  • Exhibit 09: Global immunology market: Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Pipeline landscape by development phase
  • Exhibit 19: Key clinical trials
  • Exhibit 20: Global immunology market by category 2017-2022 (%)
  • Exhibit 21: Comparison by category
  • Exhibit 22: Immunosuppressant drugs
  • Exhibit 23: Global immunosuppressants market 2017-2022 ($ billions)
  • Exhibit 24: Global immunosuppressants market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Classification of immuno boosters
  • Exhibit 26: Global immuno boosters market 2017-2022 ($ billions)
  • Exhibit 27: Global immuno boosters market: Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by category
  • Exhibit 29: Brief history of immuno-oncology
  • Exhibit 30: Stages of anti-tumor immune response
  • Exhibit 31: Customer landscape
  • Exhibit 32: Global immunology market by geography 2017-2022 (%)
  • Exhibit 33: Regional comparison
  • Exhibit 34: Immunology market in Americas 2017-2022 ($ billions)
  • Exhibit 35: Immunology market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top three countries in Americas
  • Exhibit 37: Immunology market in EMEA 2017-2022 ($ billions)
  • Exhibit 38: Immunology market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Top three countries in EMEA
  • Exhibit 40: Immunology market in APAC 2017-2022 ($ billions)
  • Exhibit 41: Immunology market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 42: Top three countries in APAC
  • Exhibit 43: Market opportunity
  • Exhibit 44: Rise in organ transplantation in US 2015-2016
  • Exhibit 45: Organ transplantation by donor type 2016
  • Exhibit 46: Vendor landscape
  • Exhibit 47: Landscape disruption
  • Exhibit 48: Vendors covered
  • Exhibit 49: Vendor classification
  • Exhibit 50: Market positioning of vendors
  • Exhibit 51: AbbVie: Vendor overview
  • Exhibit 52: AbbVie: Business segments
  • Exhibit 53: AbbVie: Organizational developments
  • Exhibit 54: AbbVie: Geographic focus
  • Exhibit 55: AbbVie: Segment focus
  • Exhibit 56: AbbVie: Key offerings
  • Exhibit 57: Amgen: Vendor overview
  • Exhibit 58: Amgen: Business segments
  • Exhibit 59: Amgen: Organizational developments
  • Exhibit 60: Amgen: Geographic focus
  • Exhibit 61: Amgen: Segment focus
  • Exhibit 62: Amgen: Key offerings
  • Exhibit 63: F. Hoffmann-La Roche: Vendor overview
  • Exhibit 64: F. Hoffmann-La Roche: Business segments
  • Exhibit 65: F. Hoffman-La Roche: Organizational developments
  • Exhibit 66: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 67: F. Hoffmann-La Roche: Segment focus
  • Exhibit 68: F. Hoffmann-La Roche: Key offerings
  • Exhibit 69: Johnson & Johnson: Vendor overview
  • Exhibit 70: Johnson & Johnson: Business segments
  • Exhibit 71: Johnson & Johnson: Organizational developments
  • Exhibit 72: Johnson & Johnson: Geographic focus
  • Exhibit 73: Johnson & Johnson: Segment focus
  • Exhibit 74: Johnson & Johnson: Key offerings
目次
Product Code: IRTNTR20037

About Immunology

The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

Technavio's analysts forecast the global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

Other Prominent Vendors

  • Angimmune
  • Bionor Pharma
  • Boston Biomedical
  • Celgene
  • Cellectar Biosciences
  • eFFECTOR Therapeutics
  • Forty Seven
  • HANSOH
  • Immatics Biatechnologies
  • lmmunovaccine
  • Karyopharm Therapeutics
  • MabVax Therapeutics
  • MedImmune
  • MOLOGEN
  • Neon Therapeutics
  • NewLink Genetics
  • Novartis
  • ONCOQUEST
  • Oncotherapeutics.

Market driver

  • Growing cases of infectious diseases
  • For a full, detailed list, view our report

Market trend

  • Significant pipeline
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: PIPELINE LANDSCAPE

PART 09: MARKET SEGMENTATION BY CATEGORY

  • Segmentation by category
  • Comparison by category
  • Global immunosuppressants market
  • Global immuno boosters market
  • Market opportunity by category

PART 10: MARKET SEGMENTATION BY INDICATION

  • Autoimmune diseases
  • Oncology
  • Organ transplantation
  • Others

PART 11: CUSTOMER LANDSCAPE

PART 12: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Immunology market in Americas
  • Immunology market in EMEA
  • Immunology market in APAC
  • Market opportunity

PART 13: DECISION FRAMEWORK

PART 14: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 15: MARKET TRENDS

  • Significant pipeline
  • Collaborations and partnerships for R&D
  • Advanced diagnostic technologies

PART 16: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 17: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

PART 18: APPENDIX

  • List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.